Wisconsin could be at the center of a regional medical physics hub that would be a catalyst for scientific breakthroughs and innovative companies that transform and extend human life....
The global life sciences industry has much to learn to bridge the diversity divide in cancer clinical trial participation. The good news is advanced technology can help—it’s time to leverage such modern innovations as artificial intelligence (AI), digital tools, and analytics software to move the...
The University of Wisconsin–Madison ranks eighth in national research rankings for public and private universities and increased research expenditures across all fields....
Predictions for how clinical trials will evolve to better serve patients in 2023 and beyond....
A strong shift to decentralized clinical trials, regulatory changes, and an increased focus on diversity were among the main industry talking points in 2022....
BioForward's Lisa Johnson discusses the strength of Wisconsin's biohealth sector....
One development that has helped the clinical trials industry evolve is the shift to digital technologies....
UW–Madison earned the designation based on its significant, sustainable and campus-wide commitment to economic engagement, including its past and future focus on innovation and entrepreneurship, technology transfer, talent and workforce development and public service and community engagement....
A new report highlights the statewide biohealth industry as a leading economic growth and innovation driver for Wisconsin....
The majority of cancers do not have known screening markers, so research is needed to be sure potential biomarkers are predictive of disease, reduce mortality, do not lead to unnecessary procedures or needless worry, and are cost-effective....
